This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Aratana Therapeutics Nv. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Inventor Spotlight: Eleonora Kiss
Introduction
Eleonora Kiss is an innovative inventor based in Brussels, Belgium. She holds a significant patent that showcases her expertise in chemical compounds, specifically in the preparation of cyclopropane derivatives. Her work contributes to advancements in medicinal chemistry, reflecting her commitment to innovation in the pharmaceutical field.
Latest Patents
Eleonora Kiss is credited with one noteworthy patent: the "Method for preparing cyclopropane derivatives." This invention focuses on the synthesis of a particular cyclopropane derivative, namely 2-amino-9-[[(1S,2R)-1,2-bis(hydroxymethyl)cyclopropyl]methyl]-4,8-dihydro-1H-purin-6-one. The patent details a method involving the [(1S,7R)-4-phenyl-3,5-dioxabicyclo[5.1.0]octan-1-yl]methanol intermediate, providing an innovative approach to producing complex organic molecules.
Career Highlights
Eleonora is affiliated with Aratana Therapeutics NV, a company that specializes in developing innovative therapeutics for animals. Her role in this organization underscores her dedication to creating effective solutions in the health sector. Her contributions extend the boundaries of traditional therapeutic options, highlighting her as a key figure in her field.
Collaborations
Throughout her career, Eleonora has worked alongside esteemed colleagues like Erwin Blomsma and Serge De Bruijn. These collaborations foster a rich environment of shared ideas and collective problem-solving, enhancing the development of innovative pharmaceuticals and methods in their projects.
Conclusion
Eleonora Kiss stands out as a remarkable inventor whose work in the preparation of cyclopropane derivatives represents the intersection of chemistry and innovation. Her patent not only reflects her individual talent but also her collaborative spirit within Aratana Therapeutics NV. As she continues to push the boundaries of research, Eleonora remains a vital contributor to advancements in medicinal chemistry, paving the way for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile